Zeledón Mariela, Eckart Nicole, Taub Margaret, Vernon Hilary, Szymanksi Megan, Wang Ruihua, Chen Pei-Lung, Nestadt Gerry, McGrath John A, Sawa Akira, Pulver Ann E, Avramopoulos Dimitrios, Valle David
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD ; Predoctoral Training Program in Human Genetics, Johns Hopkins University School of Medicine, Baltimore, MD ; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD.
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD ; Predoctoral Training Program in Human Genetics, Johns Hopkins University School of Medicine, Baltimore, MD.
Mol Neuropsychiatry. 2015 May;1(1):36-46. doi: 10.1159/000371518. Epub 2015 Feb 27.
We previously reported genetic linkage for Schizophrenia (SZ) (NPL of 4.7) at 10q22 in the Ashkenazi Jewish (AJ) population. In follow up fine mapping we found strong evidence of association between three intronic single nucleotide variants (SNVs) in the 5' end of Neuregulin 3 ( and the delusion factor score of our phenotypic principal component analysis. Two independent groups replicated these findings, indicating that variants in confer risk for a delusion-rich SZ subtype. To identify the causative variants, we sequenced the 162 kb linkage disequilibrium (LD) block covering the 5' end in 47 AJ SZ patients at the extremes of the delusion factor quantitative trait distribution. Among the identified variants we found 5 noncoding SNVs present on the high delusion factor haplotype and significantly overrepresented in high delusion factor subjects. We tested these for regulatory effects and found that risk alleles of rs10883866 and rs60827755 decreased and increased, respectively, the expression of a reporter gene as compared to the reference allele. In post-mortem brain RNA quantification experiments we found the same variants also perturb relative expression of alternative isoforms. In summary, we have identified regulatory SNVs contributing to the association of with delusion symptoms in SZ.
我们之前报道过,在阿什肯纳兹犹太(AJ)人群中,精神分裂症(SZ)与10q22存在遗传连锁(NPL为4.7)。在后续的精细定位研究中,我们发现神经调节蛋白3(Neuregulin 3)5'端的三个内含子单核苷酸变异(SNV)与我们表型主成分分析中的妄想因子得分之间存在强烈的关联证据。两个独立的研究小组重复了这些发现,表明这些变异会增加富含妄想的SZ亚型的患病风险。为了确定致病变异,我们对47名处于妄想因子数量性状分布极端的AJ SZ患者中覆盖Neuregulin 3 5'端的162 kb连锁不平衡(LD)区域进行了测序。在鉴定出的变异中,我们发现5个非编码SNV存在于高妄想因子单倍型上,并且在高妄想因子受试者中显著富集。我们对这些变异进行了调控作用测试,发现与参考等位基因相比,rs10883866和rs60827755的风险等位基因分别降低和增加了报告基因的表达。在死后大脑RNA定量实验中,我们发现相同的变异也会干扰Neuregulin 3可变剪接异构体的相对表达。总之,我们已经鉴定出了导致Neuregulin 3与SZ妄想症状关联的调控SNV。